Swine flu vaccine, Pandemrix, from GlaxoSmithKline (GSK), has been approved by the European Medicines Agency. Another, made by Baxter, is being evaluated.
The plan is to vaccinate 1,000 children between the ages of six months and 12 years over the next few weeks to see which of the two vaccines performs the best. Professor Andrew Pollard, from the University of Oxford, told the Press Association that the trial will compare the two vaccines head-to-head to see which one works best in children and causes the fewest side-effects.
Really? And just how Continue reading